Dermatoscopy: Pattern analysis of pigmented and non-pigmented lesions
“Dermatoscopy: Pattern analysis of pigmented and non-pigmented lesions” is a comprehensive guide to the use of dermatoscopy in diagnosing pigmented and non-pigmented skin lesions.
SCARD Inc is the next evolution of the Skin Cancer Audit and Research Database, also known as the SCARD Surgical Audit.
Nodular melanoma: five consecutive cases in a general practice with polarized and non-polarized dermatoscopy and dermatopathology
The fourth publication utilizing SCARD (and part of 3 papers by the same research team) was in May 2022 with the Australasian Journal of Dermatology in a paper called “Characteristics, treatment, and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database.”
Prediction without Pigment: a decision algorithm for non-pigmented skin malignancy
The fourth publication utilizing SCARD (and part of 3 papers by the same research team) was in May 2022 with the Australasian Journal of Dermatology in a paper called “Characteristics, treatment, and outcomes of 589 melanoma patients documented by 27 general practitioners on the Skin Cancer Audit Research Database.”
The impact of subspecialization
The second publication utilizing SCARD was in the International Journal of Dermatology in a paper called “The impact of subspecialization and dermatoscopy use on accuracy of melanoma diagnosis among primary care doctors in Australia.”
The SCARD Initiative
The first publication about SCARD was in the International Journal of Dermatology in a paper called “Measuring Performance in skin cancer practice: the SCARD Initiative.”